ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

US Expansion for DSCSA: Juleb Helps Companies Achieve Compliance Before the Deadline and Avoid Fines

By: Zexprwire

Doha, Qatar, 4th March 2025, ZEX PR WIRE, Web Summit Qatar sets the stage for big announcements, and this year, Juleb, the leading Track & Trace compliance solution in Saudi Arabia, is making waves. Known for its powerful and modular ERP tailored for the pharmaceutical sector, Juleb has officially unveiled its US expansion strategy, aiming to help companies achieve full DSCSA (Drug Supply Chain Security Act) compliance ahead of looming deadlines—while avoiding costly fines and operational risks.

 

Juleb: Pioneering Track & Trace Compliance in the GCC

Founded with a mission to streamline and digitize the pharmaceutical supply chain, Juleb has become a market leader in Saudi Arabia for Track & Trace compliance. Its AI-powered ERP platform provides end-to-end solutions designed to meet complex regulatory requirements while improving operational efficiency for manufacturers, re-packagers, wholesalers and pharmacy retailers.

Juleb’s modular approach allows businesses to tailor the ERP to specific operational needs, whether it’s enhancing inventory management, simplifying B2B sales, or ensuring full regulatory compliance. The system seamlessly integrates with existing ERPs and WMSs  offers real-time visibility across the entire supply chain, making it the go-to solution for companies looking to optimize processes and reduce risks.

Currently, Many ERP and track-and-trace solutions implemented in the US pharmaceutical sector face interoperability issues, as well a massive operational slowdown due to additional required labor and reporting overhead. Juleb understands the frustration from these hurdles and solves both problems seamlessly. Juleb handles all the aggregation file formats from other software providers, so companies would gain peace of mind from knowing that compliance is achieved with precision and ease. While operationally, with the bolt-scanning and ERP integration, the roadblocks from manual labor and reporting overheads are transforming to significantly shorter and streamlined processes, embodying the promise of operational excellence.

Expanding into the US: Helping Businesses Navigate DSCSA Compliance

With the DSCSA deadlines fast approaching—May 27, 2025, for manufacturers and repackagers, August 27, 2025, for wholesalers, and November 27, 2025, for larger dispensers—US-based Pharmaceutical companies and accredited Drug  Distributors are racing to align their operations with the new regulations.

Non-compliance comes with heavy penalties:

  • Fines up to $500,000 for entities
  • Individual fines of up to $250,000
  • Suspension of licenses, product confiscations, and further civil penalties

Juleb’s expansion into the US market aims to help wholesalers, distributors, and manufacturers navigate these challenges. With its Track & Trace leadership in KSA and a proven track record of helping companies achieve compliance, Juleb is perfectly positioned to support US businesses in adapting to the DSCSA framework.

“A Global Vision for a Stronger Pharma Supply Chain”

“Web Summit Qatar is the ideal platform to announce our US expansion,” said Yousuf Jamjoom, CEO of Juleb. “Our mission has always been to empower the pharmaceutical supply chain through smart, scalable solutions. As DSCSA deadlines loom, we’re stepping in to ensure companies can focus on what matters—delivering quality medications—while we handle the complexities of compliance.”

Juleb’s US strategy includes:

  • Targeting small-to-medium wholesalers for early DSCSA compliance
  • Localized modules tailored for US regulatory requirements
  • Dedicated support teams for onboarding and compliance audits
  • AI-powered analytics for real-time compliance tracking

What Makes Juleb Different?

  • Track & Trace Expertise: #1 in KSA, now bringing its leadership to the US market
  • Modular ERP: Serving manufacturing, wholesale and retail with scalable solutions
  • Real-Time Visibility: Advanced BI dashboards to support data-driven decision-making
  • Fast Deployment: Helping businesses go from complex processes to streamlined operations in weeks
  • Cost-Efficiency: Avoid heavy fines and reduce operational inefficiencies

Looking Ahead: Juleb’s Bigger Expansion Plans

While the US expansion is a major focus, Juleb has its sights set on broader global opportunities. With over 40 countries implementing Track & Trace regulations, Juleb aims to become a global leader in pharmaceutical supply chain solutions, helping companies comply with evolving regulatory frameworks while optimizing their operations.

The company is also investing in AI-powered tools, enhancing warehouse mobility solutions, and developing B2B sales force mobility features, fostering a more interconnected and efficient pharma supply chain to ensure their partners are future-ready and equipped to excel.

For more information, You can Visit our website- https://juleb.com/dscsa

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.